Chronic Rhinosinusitis Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You took part in an earlier related study (reference EK 1044/2020) and have continued taking Dupilumab without stopping since then (this will be based on what you report yourself, as there is no lab test to check this).
- You have signed and dated a consent form agreeing to take part.
- You are currently being treated with Dupilumab.
Who may not be able to join:
- You are pregnant (checked using a urine pregnancy test).
- You have significantly abnormal blood test results or an active infection such as tuberculosis, HIV, or hepatitis A, B, or C.
- You have a history of cancer or a condition that weakens the immune system.
- You have chronic obstructive pulmonary disease (COPD) or other conditions that cause blocked or narrowed airways in the lungs (confirm with trial site).
- You have needed steroid tablets or injections (systemic corticosteroids) in the month before your screening appointment.
- You have a condition called eosinophilic pneumonia or Churg-Strauss Syndrome (a rare inflammatory condition affecting blood vessels) (confirm with trial site).
- You have previously had a severe allergic reaction (anaphylaxis) or have any reason you should not take aspirin (ASA), as listed in the official medication guidance.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sven Schneider Dr. med. univ., MD, Senior doctor and Department of Otorhinolaryngology at Medical University of Vienna
Phone: 014040033480
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in ASA tolerance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.